Experienced in Diabetic Neuropathy

Dr. Andrew Ahmann

Endocrinology
OHSU Hospital
3181 SW Sam Jackson Park Rd, 
Portland, OR 

Experienced in Diabetic Neuropathy
OHSU Hospital
3181 SW Sam Jackson Park Rd, 
Portland, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrew Ahmann is an Endocrinologist in Portland, Oregon. Dr. Ahmann is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

His clinical research consists of co-authoring 60 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in OR
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
ATRIO Health
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
SelectHealth
  • HMO
  • POS
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 24 Less Insurance Carriers -

Locations

OHSU Hospital
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Call: 503-494-3273

Additional Areas of Focus

Dr. Ahmann has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Enrollment Status: Completed
Publish Date: February 10, 2026
Intervention Type: Drug
Study Drugs: Glimepiride, Sitagliptin, Liraglutide, Insulin (glargine)
Study Phase: Phase 3
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
Enrollment Status: Active_not_recruiting
Publish Date: November 09, 2020
Intervention Type: Other, Biological
Study Drug: TOL-3021
Study Phase: Phase 2
Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)
Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)
Enrollment Status: Completed
Publish Date: September 12, 2019
Intervention Type: Device
Study Phase: Not Applicable
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

60 Total Publications

A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.
Journal: Obstetrical & gynecological survey
Published: December 30, 2025
View All 60 Publications
Similar Doctors
Experienced in Diabetic Neuropathy
Dr. Farahnaz Joarder
Endocrinology
Experienced in Diabetic Neuropathy
Dr. Farahnaz Joarder
Endocrinology

Office

3181 SW Sam Jackson Park Rd Ste 140, 
Portland, OR 
 (0.6 miles away)
503-418-4500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Farahnaz Joarder is an Endocrinologist in Portland, Oregon. Dr. Joarder is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Neuropathy.

Experienced in Diabetic Neuropathy
Dr. Jessica Castle
Endocrinology
Experienced in Diabetic Neuropathy
Dr. Jessica Castle
Endocrinology

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (0.1 miles away)
503-494-5732
Languages Spoken:
English
See accepted insurances

Jessica Castle is a primary care provider, practicing in Endocrinologist in Portland, Oregon. Dr. Castle is rated as a Distinguished provider by MediFind in the treatment of Diabetic Neuropathy. Her top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), Diabetic Neuropathy, and Gastrostomy.

Experienced in Diabetic Neuropathy
Dr. Katherine Chubinskaya
Endocrinology
Experienced in Diabetic Neuropathy
Dr. Katherine Chubinskaya
Endocrinology

Diabetes Endocrine And Weight Management At PeaceHealth Salmon Creek Clinic

2312 NE 129th St Ste 120, 
Vancouver, WA 
 (15.9 miles away)
360-546-8900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Katherine Chubinskaya is an Endocrinologist in Vancouver, Washington. Dr. Chubinskaya is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. Her top areas of expertise are Adrenal Insufficiency Pediatric, Isolated Hypogonadotropic Hypogonadism, Hypopituitarism, and Kallmann Syndrome.

VIEW MORE DIABETIC NEUROPATHY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ahmann's expertise for a condition
ConditionClose
  • Elite
  • Type 1 Diabetes (T1D)
    Dr. Ahmann is
    Elite
    . Learn about Type 1 Diabetes (T1D).
    See more Type 1 Diabetes (T1D) experts
  • Distinguished
  • Low Blood Sugar
    Dr. Ahmann is
    Distinguished
    . Learn about Low Blood Sugar.
    See more Low Blood Sugar experts
  • Type 2 Diabetes (T2D)
    Dr. Ahmann is
    Distinguished
    . Learn about Type 2 Diabetes (T2D).
    See more Type 2 Diabetes (T2D) experts
  • Advanced
  • Maturity Onset Diabetes of the Young
    Dr. Ahmann is
    Advanced
    . Learn about Maturity Onset Diabetes of the Young.
    See more Maturity Onset Diabetes of the Young experts
  • Experienced
  • Diabetic Nephropathy
    Dr. Ahmann is
    Experienced
    . Learn about Diabetic Nephropathy.
    See more Diabetic Nephropathy experts
  • Diabetic Neuropathy
    Dr. Ahmann is
    Experienced
    . Learn about Diabetic Neuropathy.
    See more Diabetic Neuropathy experts
  • Diabetic Retinopathy
    Dr. Ahmann is
    Experienced
    . Learn about Diabetic Retinopathy.
    See more Diabetic Retinopathy experts
  • Rabson-Mendenhall Syndrome
    Dr. Ahmann is
    Experienced
    . Learn about Rabson-Mendenhall Syndrome.
    See more Rabson-Mendenhall Syndrome experts
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.